- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/44 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere
Patent holdings for IPC class C07K 16/44
Total number of patents in this class: 1625
10-year publication summary
|
117
|
124
|
142
|
143
|
150
|
147
|
152
|
134
|
122
|
37
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Yale University | 2204 |
48 |
| Siwa Corporation | 60 |
37 |
| Hoffmann-La Roche Inc. | 3060 |
34 |
| Janssen Pharmaceutica N.V. | 3839 |
34 |
| F. Hoffmann-La Roche AG | 7958 |
29 |
| The Regents of the University of California | 18943 |
27 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
24 |
| ARK Diagnostics, Inc. | 30 |
22 |
| Northern Bank Limited | 69 |
22 |
| Saladax Biomedical Inc. | 69 |
21 |
| Jiangnan University | 1410 |
20 |
| MacroGenics, Inc. | 267 |
19 |
| Siemens Healthcare Diagnostics Inc. | 1946 |
16 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
15 |
| Genentech, Inc. | 3742 |
14 |
| President and Fellows of Harvard College | 5792 |
14 |
| IBC Pharmaceuticals, Inc. | 99 |
14 |
| Board of Regents, The University of Texas System | 5370 |
13 |
| Academia Sinica | 888 |
13 |
| Amgen Inc. | 3779 |
11 |
| Other owners | 1178 |